Cargando…
THU670 Serum TSI Concentration In Patients With Graves’ Disease Undergoing Maintenance-dose Of Antithyroid Drug (ATD) And Its Relationship With Disease Relapse After ATD Withdrawal
Disclosure: P.V. Nguyen: None. K.T. Nguyen: None. Background: Graves' disease (GD) is an autoimmune disorder in which thyroid-stimulating immunoglobulin (TSI) plays a key role in its pathogenesis. TSI assays have been recently optimized in their accuracy, and the procedure has also been simplif...
Autores principales: | Nhat Nguyen, Phong Vu, Thy Nguyen, Khue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554511/ http://dx.doi.org/10.1210/jendso/bvad114.1793 |
Ejemplares similares
-
A case of antithyroid drug‐induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment
por: Kim, Hyunsam, et al.
Publicado: (2018) -
SUN-503 Thyroid Storm Followed by ATD Induced Agranulocytosis in Late Pregnancy: A Management Dilemma
por: Aljehani, Faisal, et al.
Publicado: (2020) -
ATD Talent Management Handbook
por: Bickham, Terry
Publicado: (2015) -
Lithium Carbonate in the Treatment of Graves' Disease with ATD-Induced Hepatic Injury or Leukopenia
por: Zheng, Rendong, et al.
Publicado: (2015) -
SAT462 TSI Versus TRAb In The Diagnosis Of Grave’s Disease
por: Ibrahim, Katherine, et al.
Publicado: (2023)